Drug Discovery 2022: driving the next life science revolution

David Madge

No Image
David Madge
Vice President, Discovery Services
WuXi AppTec

Presentations at Drug Discovery 2022: driving the next life science revolution

Profile of David Madge

Dr Dave Madge is Vice President of the Discovry Services team in WuXi AppTec. In this role Dave leads business development in Europe and Israel, alongside a portfolio of strategic initiatives across multiple therapeutic areas and modalities. Prior to joining WuXi AppTec, in 2014, Dave was VP, Research, for the ion channel drug discovery company Xention Ltd, in Cambridge, UK, developing new molecules for cardiovascular and respiratory disorders. Before Xention Dave was based at University College London, as part of an integrated biomedical research group, and was responsible for developing new therapeutic discovery projects into funded biotech companies. Dave has a PhD in Medicinal Chemistry from Imperial College, London, and started his career at The Wellcome Foundation in the medicinal chemistry team.


Mrs Ambreen Anwer
Business Development Manager
WuXi AppTec
Dr Nick Camp
Project Manager
WuXi AppTec


Please login to send a Private Message

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'